Werewolf Therapeutics, Inc.
HOWL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $90,234 | $49,030 | $43,581 | $65,830 |
| - Cash | $66,609 | $78,491 | $92,042 | $110,995 |
| + Debt | $9,644 | $37,146 | $37,014 | $37,087 |
| Enterprise Value | $33,269 | $7,685 | -$11,447 | -$8,078 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$406 | -$426 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15,324 | -$16,275 | -$16,400 | -$18,691 |
| % Margin | – | – | – | – |
| Net Income | -$16,370 | -$17,982 | -$18,089 | -$20,400 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.4 | -0.4 | -0.46 |
| % Growth | 10% | 0% | 13% | – |
| Operating Cash Flow | -$15,156 | -$15,164 | -$18,948 | -$14,252 |
| Capital Expenditures | $0 | $0 | $0 | -$123 |
| Free Cash Flow | -$15,156 | -$15,164 | -$18,948 | -$14,375 |